There has recently been some misunderstanding about CBD case, cannabis light and hemp in Italy. All because of recent regulation from Italian Ministry of Health. Having a thorough understanding of the subject is essential. That is why we will look at this case below.
Cannabis, CBD: available products & media confusion
A cannabis version, known in Italy as “cannabis light”, contains relatively little THC. It typically has from 0.2% to 0.6% THC. Contrary to some false media stories, it is legal to buy cannabis light in Italy from both specialised shops and online.
The same applies to cosmetics containing CBD. The latest ruling has no impact here as well. These products, which include creams, oils, and other beauty supplies, work with the EU Regulation No. 1223/2009, which places Italy in line with the rest of Europe.
Hemp is both a crop for agriculture and an industrial plant under the Treaty on the Functioning of the European Union (TFEU), which the EU Regulation No. 220/2015 supports. The use of the plant’s apical sections, or hemp flowers, has recently been approved by the Administrative Court of the Lazio Region. This complies with international and European laws as well as Italian Law 242/16.
The main thing that the new regulation in Italy aims to govern is CBD oil. Fundamental to understanding the Ministry of Health’s decree, although it may be confusing, is that it only refers to “oral compositions containing CBD extracted from the plant” for medical purposes. Thus, hemp flowers, CBD cosmetics and cannabis light are legal and can be available on the market without limitation.
Recent CBD regulation in Italy vs. the rest of the world
Staying informed is essential. As stated, the Ministry of Health’s regulation only applies to “oral compositions containing CBD extracted from the plant”. It does not affect the accessibility of hemp flowers, which are still offered in specialised shops.
That is why some hemp industry organisations like Canapa Sativa Italia voiced opposition to the decree and emphasised its lack of scientific support. They requested that the Ministry of Health revoke the order and open the door to discussion with the administration. They want to include trade associations in the regulatory decisions which can control the industry according to the academic research.
International organisations like the WHO and the United Nations endorse the idea that CBD is a risk-free modifying agent with no misuse potential or intoxication effects. WHO Expert Committee on Drug Dependence (ECDD) conclude that cannabidiol does not appear to have abuse potential or cause harm.
CBD in real life
Real-life testimonies and experiences depict a clear picture: The usage of CBD-based products can help consumers use fewer potentially dangerous substances. Moreover, CBD shows evidences to be a treatment for many diseases. As we recently wrote, CBD was designed as orphan drug for Leigh syndrome. It shows potential also as a treatment option in case of acne and Alzheimer’s disease.
A fair and knowledgeable viewpoint is necessary for navigating the CBD and its legal landscape. It is crucial to stay educated, keep critical thinking, and base decisions on scientific fact as we adjust to a legal landscape that is always changing.